Transaction #34048 · Form 4 · 0001612528-26-000002
Mineralys Therapeutics, Inc. · Stock award · Stock Option
Mineralys Therapeutics, Inc. · Transacted October 19, 2026 · Filed October 20, 2026
What does this filing report?
An SEC Form 4 filing for Mineralys Therapeutics, Inc. records a stock award involving Stock Option on October 19, 2026. The reported quantity was 16,600. The filing date is October 20, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Mineralys Therapeutics, Inc.
- Company CIK
- 0001933414
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 16,600
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 16,600
- Ownership description
- Not reported
- SEC acceptance time
- Oct 20, 2026, 5:32 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- COATS LONNEL ↗
Director
CIK 0001612528
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 16,600
- Conversion / exercise price
- 20.92
- Exercise date
- Not reported
- Expiration date
- October 19, 2036
Filing footnotes & remarks
- F1
- Consists of restricted stock units (RSUs) granted for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting. The RSUs vest in annual installments over a period of three years, with 1/3rd of the RSUs vesting on each one-year anniversary of the grant date, subject to the reporting person's continued service through each applicable vesting date.
- F2
- The shares underlying the stock option vest in monthly installments over a period of three years, with 1/36th of the underlying shares vesting on each monthly anniversary of the grant date, subject to the reporting person's continued service through each applicable vesting date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.